News

Jul 10, 2020
BE spinout Sherlock Biosciences is using a gene-editing system in coronavirus tests approved for use in health care — the first CRISPR product to reach the market.
Jul 2, 2020
In a study led by graduate student Lauren Stopfer, researchers used the platform to analyze the effect of CDK4/6 inhibitors, a class of known anticancer agents, on the immunopeptidome of melanoma cell lines.
Jun 29, 2020
By folding DNA into a virus-like structure, MIT researchers have designed HIV-like particles that provoke a strong immune response from human immune cells grown in a lab dish.
Jun 26, 2020
“Our new indicator makes the signals more accurate. This suggests that the signals that people are measuring with regular GCaMP could include crosstalk,” Boyden says.
Jun 17, 2020
It was Omar Abudayyeh PhD who helped turn the gene-editing tool CRISPR into a diagnostic test, one that might help slow down the covid-19 pandemic.
Jun 17, 2020
Leila Pirhaji PhD among this year's MIT Technology Review's 35 brilliant young entrepreneurs, inventors, visionaries, humanitarians and pioneers who are working to make the world a better place.  
Jun 8, 2020
“Knowing how much antigen is present in tumor cells could inform what kind of therapies we develop and our ability to make informed decisions about immunotherapy options.”
May 20, 2020
Two BE faculty among six from MIT awarded research funding to address Covid-19 from the Massachusetts Consortium on Pathogen Readiness (MassCPR).
May 14, 2020
Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.  
Apr 30, 2020
MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.